tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Income Statement

Compare
87 Followers

Cipher Pharmaceuticals Income Statement

Last quarter (Q3 2025), Cipher Pharmaceuticals's total revenue was $12.83M, an increase of 23.75% from the same quarter last year. In Q3, Cipher Pharmaceuticals's net income was $5.50M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 33.36M$ 21.16M$ 20.68M$ 21.94M$ 21.61M
Gross Profit
$ 24.10M$ 17.09M$ 16.68M$ 18.26M$ 18.55M
Operating Expenses
$ 16.25M$ 5.56M$ 5.63M$ 6.45M$ 6.39M
Depreciation and Amortization
$ 4.02M$ 1.23M$ 989.00K$ 701.00K$ 1.21M
EBITDA
$ 11.87M$ 11.53M$ 12.04M$ 13.66M$ 13.40M
Operating Income
$ 7.85M$ 11.53M$ 12.04M$ 11.82M$ 12.20M
Other Income/Expenses
$ -4.89M$ 1.15M$ -560.00K$ -2.00M$ -5.63M
Pretax Income
$ 2.96M$ 12.68M$ 11.48M$ 11.06M$ 6.54M
Net Income
$ 11.54M$ 20.38M$ 26.64M$ 7.76M$ 4.55M
Per Share Metrics
Basic EPS
$ 0.46$ 0.80$ 1.06$ 0.29$ 0.17
Diluted EPS
$ 0.47$ 0.80$ 1.04$ 0.29$ 0.17
Weighted Average Shares Outstanding
24.72M 25.48M 25.13M 26.60M 27.03M
Weighted Average Shares Outstanding (Diluted)
24.57M 25.42M 25.59M 26.83M 27.37M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History